MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Prevalence of depression and dementia in Parkinson’s disease

A. Kalendarev, F. Yunusov, G. Rakhimbaeva (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 1363

Keywords: Dementia

Session Information

Date: Wednesday, June 22, 2016

Session Title: Cognitive disorders

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: The aim of this study was to estimate the prevalence of depressive and dementia symptoms in PD patients.

Background: Parkinson’s disease (PD) is a neurodegenerative disorder causing not only motor dysfunction but also cognitive, psychiatric, autonomic and sensory disturbances. Depression is the most common psychiatric disturbance identified in patients with PD and has been shown to be more common in PD than in other chronic and disabling disorders, occurring in approximately 40% of PD patients. However, the prevalence and clinical features associated with depression in PD remain controversial. Dementia is increasingly recognized as a symptom associated with idiopathic PD, and is found in up to 40% of all patients suffering from that condition.

Methods: The study included 19 consecutive patients with PD, 7 (36.8%) male and 22 (63.2%) female (mean age 60.3 ± 9.0, range 45-79 years), mean duration of disease 4.1 ± 2.6 (range 1-10) years, hospitalized during two years at Department of Neurology, Tashkent Medical Academy Hospital, Tashkent, Uzbekistan. The Mini Mental State Examination (MMSE) was used for assessment of cognitive deterioration and Beck Depression Inventory (BDI) for depression. Computerized tomography was performed in all patients.

Results: According to BDI scale, depressive symptoms were present in all 19 PD patients: minimal in 2 (10.5%), low in 4 (21%), moderate in 5 (26.3%), severe in 4 (21%) and extreme in 4 (21%) patients. On MMSE scale, 5 (26.3%) patients were free from cognitive deterioration and 14 (73.7%) patients had moderate to severe deterioration, but 11 (57.9%) patients (6 (54.5%) male and 5 (45.5%) female) had symptoms of dementia (MMSE score ≤ 23). Very mild symptoms of dementia were found in 3 (15.8%) and overt features of dementia in 11 (57.9%) PD patients.

Conclusions: So, out of 19 PD study patients, 14 (73.7%) had symptoms of dementia (MMSE score ≤ 23). In conclusion, depressive and dementia symptoms are common in PD patients.

To cite this abstract in AMA style:

A. Kalendarev, F. Yunusov, G. Rakhimbaeva. Prevalence of depression and dementia in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/prevalence-of-depression-and-dementia-in-parkinsons-disease/. Accessed May 25, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/prevalence-of-depression-and-dementia-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley